AG

Aishwarya Gaddalay

Active Director Designated Partner DIN 09053496
DIN 09053496 First appointment Feb 2021 Primary industry Transportation
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Aishwarya Gaddalay

Data last updated:

Aishwarya Gaddalay is a Designated Partner at Saral Samruddhi Biotech Llp (since 2021). The company operates in Transportation.

DIN 09053496
Primary Designation Designated Partner
Industry Transportation
First Appointment 06 Feb 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner06 Feb 20212021Active

Board colleagues of Aishwarya Gaddalay

Directorship timeline

Open interactive timeline →
Saral Samruddhi Biotech Llp
Premium access

Shareholding and investment profile for Aishwarya Gaddalay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aishwarya Gaddalay

Aishwarya Gaddalay currently holds 1 directorship: Saral Samruddhi Biotech Llp (Designated Partner, since 06 Feb 2021).

Aishwarya Gaddalay was first appointed on 06 Feb 2021 as Designated Partner at Saral Samruddhi Biotech Llp.

The current boards of Aishwarya Gaddalay's companies include Basavaraj Andappa Gadagin (Saral Samruddhi Biotech Llp), Gaddalay Rajeshwar Rao (Saral Samruddhi Biotech Llp), Mohammad Mulla Hasan Mohiddin (Saral Samruddhi Biotech Llp), Soma Shekar Hosmani (Saral Samruddhi Biotech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available